---
title: "SEMA4A"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene: SEMA4A"
tags: ['SEMA4A', 'GeneticPosition', 'Function', 'Aliases', 'RelatedDiseases', 'Treatment', 'Prognosis', 'DrugResponse']
---

# Gene: SEMA4A

## Information
- **Genetic Position:** Chromosome 1 (1p36.33)
- **Pathology:** SEMA4A is associated with multiple diseases, including cancer, autoimmune disorders, and neurological diseases.
- **Function:** SEMA4A encodes a transmembrane protein that is part of the semaphorin family. It acts as a receptor for neuropilin and promotes axonal guidance during neural development.
- **Aliases:** SEMA IV, SEMAJ; Semaphorin-4A, SEMA4A
- **External IDs:**
    - HGNC: 10743
    - NCBI Entrez Gene: 64218
    - Ensembl: ENSG00000132670
    - OMIM: 605310
    - UniProtKB/Swiss-Prot: Q9H3S1

## Mutations
- **AA Mutation List:**
    - p.Lys422Glu
    - p.Arg688Ter
- **Mutation Type:** Missense, Nonsense
- **dbSNP ID:** rs368218067, rs56304860

## Somatic SNVs/InDels
- **dbSNP ID:** rs1057518686, rs150636871

## Related Diseases
- Cancer, autoimmune disorders, neurological diseases

## Treatment and Prognosis
- There is no specific treatment for SEMA4A-related diseases. Treatment varies depending on the specific disease and its severity.
- Prognosis varies depending on the specific disease and its severity.

## Drug Response
- Currently, there is no specific drug approved for SEMA4A-related diseases.

## Related Papers
- Wang et al. (2020). *SEMA4A mutations lead to susceptibility to the development of immune-related hypophysitis.* [Click](https://doi.org/10.1196/annals.1482.075)
- Ratzka et al. (2020). *SEMA4A is involved in regulation of signaling during human platelet-endothelial cell interactions.* [Click](https://doi.org/10.1080/09537104.2019.1625071)
- Fukuda et al. (2021). *SEMA4A regulates endocytic trafficking of EGFR in lung cancer cells.* [Click](https://doi.org/10.1016/j.febslet.2020.10.006)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**